In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 2, 2000, Pages 441-443

  Moore, Caroline B ^a   Walls, Caroline M ^a   Denning, David W ^a,b,c  

^a HOPE HOSPITAL   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; CONTROLLED STUDY; DRUG SCREENING; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; DRUG RESISTANCE, MICROBIAL; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; THIAZOLES; TRIAZOLES;

EID: 0033969288     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.2.441-443.2000     Document Type: Article

References (14)

1. Berenger, J., N. M. Ali, M. C. Allende, J. Lee, K. Garrett, S. Battaglia, S. C. Piscitelli, M. G. Rinaldi, P. A. Pizzo, and T. J. Walsh. 1994. Itraconazole for experimental pulmonary aspergillosis - comparison with amphotericin-B, interaction with cyclosporin-A, and correlation between therapeutic response and itraconazole concentrations in plasma. Antimicrob. Agents Chemother. 38:1303-1308.
2. Denning, D. W. 1994. Invasive aspergillosis in immunocompromised patients. Curr. Opin. Infect. Dis. 7:456-462.
3. Denning, D. W., S. A. Radford, K. Oakley, L. Hall, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome for Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-114.
4. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-803.
5. Fung-Tomc, J. C., E. Huczko, B. Minasslan, and D. P. Bonner. 1998. In vitro activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob. Agents Chemother. 42:313-318.
6. Hata, K., J. Kimura, H. Miki, T. Toyosawa, M. Moriyama, and K. Katsu. 1996. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 40:2243-2247.
7. Hata, K., J. Kimura, H. Miki, T. Toyosawa, T. Nakamura, and K. Katsu. 1996. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob. Agents Chemother. 40:2237-2242.
8. Johnson, E., K. L. Oakley, S. Radford, C. B. Moore, P. Warn, D. W. Warnock, and D. W. Denning. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J. Antimicrob. Chemother., in press.
9. Martin, M. V., J. Yates, and C. A. Hitchcock. 1997. Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs. Antimicrob. Agents Chemother. 41:13-16.
10. Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1994. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am. J. Med. 96:497-503.
11. Oakley, K. L., C. B. Moore, and D. W. Denning. 1997. In vitro activity of SCH-56592 and comparison with amphotericin B and itraconazole against Aspergillus spp. Antimicrob. Agents Chemother. 41:1124-1126.
12. Oakley, K. L., G. Morrissey, and D. W. Denning. 1997. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1504-1507.
13. Oakley, K. L., C. B. Moore, and D. W. Denning. 1998. The in vitro activity of voriconazole against Aspergillus spp. and comparison with amphotericin B and itraconazole. J. Antimicrob. Chemother. 42:91-94.
14. Pfaller, M. A., D. A. Messer, R. J. Hollis, R. N. Lones, G. V. Doern, M. E. Brandt, and R. A. Hajjeh. 1998. In vitro susceptibilities of Candida blood-stream isolates to the new triazole antifungal agents BMS-207147, SCH 56592, and voriconazole. Antimicrob. Agents Chemother. 42:3242-3244.